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Abstract
Background: Based on the global predictions majority of deaths will be collectively caused by cancer,
cardiovascular diseases, and traffic accidents over the coming 25 years. In planning future national health
policy actions, inter – regional assessments play an important role. The purpose of the study was to analyze
similarities and differences in premature mortality between Serbia, EURO A, EURO B, and EURO C
regions in 2000.
Methods: Mortality and premature mortality patterns were analysed according to cause of death, by
gender and seven age intervals. The study results are presented in relative (%) and absolute terms (age-
specific and age-standardized death rates per 100,000 population, and age-standardized rates of years of
life lost – YLL per 1,000). Direct standardization of rates was undertaken using the standard population of
Europe. The inter-regional comparison was based on a calculation of differences in YLL structures and with
a ratio of age-standardized YLL rates per 1,000. A multivariate generalized linear model was used to
explore mortality of Serbia and Europe sub-regions with ln age-specific death rates. The dissimilarity was
achieved with a p ≤ 0.05.
Results: According to the mortality pattern, Serbia was similar to EURO B, but with a lower average YLL
per death case. YLL patterns indicated similarities between Serbia and EURO A, while SRR YLL had
similarities between Serbia and EURO B. Compared to all Europe sub-regions, Serbia had a major excess
of premature mortality in neoplasms and diabetes mellitus. Serbia had lost more years of life than EURO
A due to cardiovascular, genitourinary diseases, and intentional injuries. Yet, Serbia was not as burdened
with communicable diseases and injuries as were EURO B and EURO C.
Conclusion: With a premature mortality pattern, Serbia is placed in the middle position of the Europe
triangle. The main excess of YLL in Serbia was due to cardiovascular, malignant diseases, and diabetes
mellitus. The results may be used for assessment of unacceptable social risks resulting from health
inequalities. Within intentions to reduce an unfavourable premature mortality gap, it is necessary to
reconsider certain local polices and practices as well as financial and human resources incorporated in the
prevention of disease and injury burden.
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Background
The start of the new millennium was an appropriate time
for the examination and reform of current health policies
and practices for many countries worldwide. In addition
to financial crises, health inequalities marked the begin-
ning of the century. Based on the updated Global Burden
of Disease (GBD) Study in 2004, predictions are that >
50% of all deaths will be caused collectively by cancer, car-
diovascular diseases, and traffic accidents over the coming
25 years [1]. Other alerts involved divergent trends in glo-
bal mortality and a slowing of improvements in life
expectancy in Europe [1]. In addition, common drivers for
changes in actual policies and practices have modified
users' expectations and dissatisfaction with health system
performance. Recent actions of public health policy pro-
fessionals included setting the millennium development
goals and intensification of activities for strengthening
health system performance nationally and internationally
[2-5].
Due to awareness of the changing settings and related
financial flows, it is urgent to objectively assess national
health patterns [6]. The GBD study has assisted in the bal-
anced evaluation of health problems worldwide [7]. In
fact, the GBD study is a source for accurate information on
diseases, injuries, and risk factors for premature mortality,
morbidity, and disability [7]. Moreover, such scientific
methodology provides a specific look at the operation of
a country's health system and its supporting mechanisms.
Serbia is a small country in southeast Europe; it belongs to
the EURO B mortality stratum with respect to the low
child and adult mortality rate [8]. After a long period of
political, social, and economic instability that started with
a violent split between six Yugoslav republics (including
Serbia), the public health sector underwent reform [9].
The changes coincided with an economic transition from
centrally-planned to market-driven. In accordance with
the national orientation to enhance cross-border collabo-
ration, the changes appeared useful to explore Serbia's
mortality burden within the European context.
Former studies on the burden of diseases and injuries in
Serbia aimed to introduce professionals with contempo-
rary methodology, to include premature mortality meas-
ures in setting national health priorities, and to assess
years of life lost (YLL) patterns within country regions [10-
12]. The Serbian Burden of Disease Study [13] was con-
ducted to estimate national disability adjusted life years
due to selected diseases, injuries, and risk factors. In plan-
ning future national health policy actions, inter-regional
assessments play an important role [14,15] and are even
more instructive in circumstances of scarce financing. We
aimed to explore beneficial directions for health improve-
ment in Serbia.
The purpose of the study was to analyze the similarities
and differences in premature mortality between Serbia,
EURO A, EURO B, and EURO C regions in 2000.
Methods
The study populations were Serbia, EURO A, EURO B, and
EURO C in 2000. The population of Serbia was 7,550,855
(49% male and 51% female) [16]. The population was
estimated with backward projection from the 2002 Cen-
sus and without a migration component, but Kosovo and
Metohija were excluded due to the unavailability of data.
The Serbian electronic mortality database was obtained
from the Republic's Statistical Office [16]. Data on the
population, mortality, and YLL of EURO A, EURO B, and
EURO C were obtained from the GBD 2000 estimates
report [8,17,18].
The completeness of the Serbian mortality database was
98% in 2000 [13]. The issuing and distribution of death
certificates in the state is coordinated between the Minis-
try of Internal Affairs and the Ministry of Health [19-22].
All deaths occurring in the territory of the Republic of Ser-
bia are registered with a completed death file (certificate
of death and statistical paper DEM-2 form) [19,20]. The
procedure is consistent throughout the country and com-
prises several levels of control and verification [21,22]. A
death certificate can be obtained by an authorized physi-
cian in the health care organization, a coroner, or a foren-
sic doctor. A death file contains information on the cause
of death (coded with ICD-10), time and place of death,
clinical or forensic postmortem data, and other personal
data. The local registrar controls and forwards death files
to the referral public health institute within five days,
where another trained medical doctor or specialist con-
trols and corrects the file with Death Certificate software
within thirty days [21,22]. Authorized statistical bodies
compile regional and state unit records and annually
report to the public, but with a two-year lag. All the data
files are confidential and considered officially undisclosed
information.
For this study, mortality data with no personal identifica-
tion were classified into a comprehensive list of three
broad GBD groups, 21 categories of diseases and injuries,
and 135 specific conditions, following the structure of the
GBD list of conditions and codes [7]. The GBD methodol-
ogy was used for handling ill-defined codes or missing age
information. Therefore, 0.1% deaths with missing age
were redistributed proportionally by gender and cause. A
total of 8.7% deaths with ill-defined conditions (U161)
were redistributed proportionally by age and gender, in
the age group < 5 years – across communicable diseases,
maternal, perinatal, and nutritional conditions (U001);
and in age groups ≥ 5 years – within non-communicable
diseases (U059). Then, 3.4% of deaths assigned with codePopulation Health Metrics 2009, 7:12 http://www.pophealthmetrics.com/content/7/1/12
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U077 of malignant neoplasms were proportionally redis-
tributed by age and gender in all specified sites, and 0.7%
of ill-defined injury deaths (U162) – across all uninten-
tional injuries (U149). Also, 11% of cardiovascular dis-
eases coded U110 were redistributed to ischemic heart
disease in accordance with the GBD regression formula
[7].
In this paper, we analyzed diseases and injuries that were
responsible for approximately > 99% of male and female
mortality in Serbia in 2000. Disease categories that con-
tributed < 0.5% to overall mortality in both genders were
not presented in this analysis. Apart from the three broad
GBD groups: communicable, maternal, perinatal, and
nutritional conditions (U001), non-communicable dis-
eases (U059), and injuries (U148), this study included 12
major disease categories: infectious and parasitic diseases
(U002), respiratory infections (U038), perinatal condi-
tions (U049), malignant neoplasms (U060), diabetes
mellitus (U079), neuropsychiatric conditions (U081),
cardiovascular diseases (U104), respiratory diseases
(U111), digestive diseases (U115), genitourinary diseases
(U120), unintentional injuries (U149), and intentional
injuries (U156).
Mortality and premature mortality patterns were analyzed
according to cause of death by gender and seven age inter-
vals (0 – 4, 5 – 14, 15 – 24, 25 – 44, 45 – 54, 55 – 69, and
≥ 70 years). Consistent with the GBD Study methodology,
YLL were calculated as the number of years lost from
deaths occurring before the maximum attainable life
expectancy at birth, with a 3% time discount rate for YLL
in the future and age-weighting [7]. To make possible the
comparison with the burden of disease in other countries,
we applied the GBD Study life expectancies at birth: 82.5
years for females (the Coale and Demeny model life table
for West level 26) and 80 years for males (standard model
life table, the Second edition of West level 25, available in
the United Nations Population Division software package
MORTPAK) [23,24]. The time discount rate stands for the
net present value of a healthy life year gained in 10 years
time and is worth 24% less than one gained now. In the
absence of national age weights, we applied the GBD
Study weights representing broad social preference in
which a year of healthy life lived at young and older ages
is weighted less than for other ages [7].
The study results are presented in relative (%) and abso-
lute terms (age-specific and age-standardized death rates
per 100,000 population, and age-standardized YLL rates
per 1,000). Direct standardization of rates was undertaken
using the standard population of Europe [25]. A multivar-
iate generalized linear model (GLM) was used to explore
mortality of Serbia and European sub-regions due to
broad GBD groups with ln age-specific death rates. The
dissimilarity was achieved with a p ≤ 0.05.
The inter-regional comparison of premature mortality
patterns with respect to age, gender, and cause of death
distribution was based on a calculation of differences in
YLL structures (Serbian YLL structure minus European
sub-regional YLL structure) and with a ratio of age-stand-
ardized YLL rates per 1,000 – SRR YLL (where Serbia YLL
rates were the denominator).
The data analysis and graphic presentation were done in
MS Office 2007, while GLM was performed with SPSS for
Windows, version 15.0.
Results
Mortality patterns
In 2000 there were 104,042 deaths (52% in males and
48% in females) in Serbia. Non-communicable diseases
accounted for a large proportion of deaths in males and
females in Serbia (92% and 94%, respectively), EURO A
(88% and 90%, respectively), EURO B (82% and 88%,
respectively), and EURO C (75% and 92%, respectively).
Cardiovascular diseases and malignant neoplasms were
collectively responsible for > 60% of total mortality, while
other causes had minor shares (Table 1; see Additional file
1).
According to age-specific death rates, Serbia was signifi-
cantly different from EURO B (p < 0.005) and EURO C (p
< 0.005) for communicable, maternal, perinatal, and
nutritional conditions (Figure 1a); it had higher age-spe-
cific death rates than EURO A (p < 0.005) for non-com-
municable diseases (Figure 1b), and was dissimilar
statistically from Euro C (p < 0.002) with respect to inju-
ries (Figure 1c).
For standardized death rates, Serbia was alike EURO A for
communicable, maternal, perinatal, and nutritional con-
ditions, and similar to EURO B for non-communicable
diseases, but it had four times lower standardized death
rate of injuries than EURO C (see Additional file 2). The
four major cause categories were cardiovascular diseases,
malignant neoplasms, respiratory, and digestive diseases.
Additional causes were diabetes mellitus in Serbia, neu-
ropsychiatric conditions in EURO A, and unintentional
injuries in EURO B and EURO C. Males had higher stand-
ardized death rates than females due to all causes, with the
exception of diabetes mellitus for which the rates for both
sexes were similar (see Additional file 2).
In general, the standardized death rates were higher, par-
ticularly at ≥ 45 years in all regions. However, malignant
neoplasms start increasing at ≥ 30 years of age in males
and females of Serbia and EURO C, as do cardiovascularPopulation Health Metrics 2009, 7:12 http://www.pophealthmetrics.com/content/7/1/12
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diseases in males of all populations, except EURO A, and
in females of EURO C (see Additional file 2).
Premature mortality patterns
In Serbia, more than 800,000 total YLL were estimated,
out of which males had lost 31% more years of life than
females (Figure 2). The selected main disease categories
caused almost all of the YLL in Serbia (99%), EURO A
(96%), EURO B (97%), and EURO C (98%; Figure 3).
Most YLL in Serbia were due to cardiovascular diseases
(48%) and malignant neoplasms (24%) (Table 1).
The estimated average YLL per death for both males and
females in Serbia (9 and 7 YLL, respectively) was lower
than in EURO C (13 and 8 YLL, respectively) and EURO B
(12 and 10 YLL, respectively). On average, perinatal con-
ditions caused 33 YLL per death in both males and
females in all regions, while malignant neoplasms caused
11 YLL in EURO B, 10 YLL in Serbia and EURO C, and 7
YLL in EURO A. Male vs. female average YLL due to cardi-
ovascular diseases was 7 vs. 6 in Serbia, 6 vs. 3 in EURO A,
8 vs. 6 in EURO B, and 9 vs. 5 in EURO C.
Prior to 45 years of age, the population had already lost
19% of total YLL in Serbia, 23% in EURO A, 38% in
EURO C, and 48% in EURO B. The main causes for this
effect were injuries, neuropsychiatric conditions, infec-
tious and parasitic diseases, respiratory infections, and
perinatal conditions. Malignant neoplasms and cardio-
vascular diseases affected people aged 45 years and older.
In Serbia, total age-standardized YLL rate was 93 per
1,000. Males had higher rates then females (115 vs. 72;
see Additional file 3). Serbia had higher rates than EURO
A, but lower than EURO C and EURO B for cardiovascular
diseases, unintentional, and intentional injuries. Serbia
and EURO C had similar rates of malignant neoplasms
(Figure 4).
The analysis of premature mortality of Serbia within the
European context included a calculation of differences in
YLL structure (Figure 3), and ratios of age-standardized
YLL rates – SRR YLL (according to data in Additional file
3).
Due to cardiovascular diseases, Serbian males and females
had a surplus of YLL in comparison to their counterparts
in EURO A (by 16% and 22%, respectively), EURO B (by
12% and 15%, respectively), and EURO C (by 11% and
4%, respectively). Malignant neoplasms caused addi-
Table 1: Total number of deaths and YLL by disease categories: Serbia and European sub-regions1 in 2000
Selected disease categories (GBD Code) Serbia2 EURO A3 EURO B3 EURO C3
Deaths YLL Deaths YLL Deaths YLL Deaths YLL
All Causes (U000) 104042 814023 3986734 24749640 1868999 20493250 3604321 37067216
Communicable, maternal, perinatal and nutritional conditions 
(U001)
2350 36721 237564 1497486 174837 4571939 144426 3011811
Infectious and parasitic diseases (U002) 700 9432 49196 483596 62031 1670130 79502 1664087
Respiratory infections (U038) 1062 8729 169663 606236 67345 1447835 43875 688149
Perinatal conditions (U049) 543 18000 11428 378876 40071 1329618 18072 599816
Non-communicable diseases (U059) 97571 710402 3553238 20339741 1579829 13352506 2991428 24309564
Malignant neoplasms (U060) 19607 193978 1058472 7866460 281188 3032936 504448 5154102
Diabetes mellitus (U079) 2731 20723 89452 446206 28734 264771 21071 264771
Neuropsychiatric conditions (U081) 1362 16162 178278 1146462 24278 457106 37606 710146
Cardiovascular diseases (U104) 64013 393580 1673460 7434356 1051406 7108333 2130728 14636178
Respiratory diseases (U111) 4067 27913 213028 994519 72339 673706 122340 973063
Digestive diseases (U115) 3313 30726 183448 1346282 75004 943173 118772 1553977
Genitourinary diseases (U120) 1722 13732 60455 253777 25139 316520 26398 329485
Injuries (U148) 4121 66899 195931 2912413 114333 2568806 468468 9745841
Unintentional injuries (U149) 1964 34757 140491 1921897 79513 1778892 298377 6137215
Intentional injuries (U156) 2159 32140 55440 990516 34820 789913 170090 3608626
Other 799 14151 103922 880457 27131 680316 33044 747601
1EURO A constitute: Andorra, Austria, Belgium, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, 
Israel, Italy, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Slovenia, Spain, Sweden, Switzerland; EURO B: Albania, 
Armenia, Azerbaijan, Bosnia and Herzegovina, Bulgaria, Georgia, Kyrgyzstan, Poland, Romania, Serbia and Montenegro, Slovakia, Tajikistan, The FYR 
Macedonia, Turkey, Turkmenistan, Uzbekistan; EURO C: Belarus, Estonia, Hungary, Kazakhstan, Latvia, Lithuania, Republic of Moldova, Russian 
Federation, Ukraine [8];
2Source: Serbian Burden of Disease Study [13];
3Sources: Global Burden of Disease (GBD) 2000: version 3 estimates [17,18].Population Health Metrics 2009, 7:12 http://www.pophealthmetrics.com/content/7/1/12
Page 5 of 10
(page number not for citation purposes)
tional YLL excess in Serbian males and females in compar-
ison to EURO B (by 9.4% and 8.4%, respectively), and
EURO C (by 12% and 6.5%, respectively).
With respect to SRR YLL, Serbian males and females
resembled EURO B for cardiovascular and genitourinary
diseases and EURO C for malignant diseases and perinatal
conditions.
For SRR YLL across almost all age groups, there were
higher YLL in Serbia than in EURO A in both males and
females for cardiovascular diseases (0.4- and 0.3-fold,
respectively), malignant neoplasms (0.8- and 0.7-fold,
respectively), diabetes mellitus (0.4- and 0.3-fold, respec-
tively), genitourinary diseases (by 0.3-fold in each), inten-
tional injuries (by 0.6-fold in each), and perinatal
conditions (0.3- and 0.4-fold, respectively).
With respect to SRR YLL, there were higher YLL in Serbia
than in EURO B in both males and females for malignant
neoplasms (by 0.8-fold in each), diabetes mellitus (by
0.7-fold in each), and intentional injuries only among
those ≥ 45 years of age (in total, 0.9- and 0.8-fold, respec-
tively).
With respect to SRR YLL, there were higher YLL in Serbia
than in EURO C in both males and females for diabetes
mellitus (0.6- and 0.4-fold, respectively), and genitouri-
nary diseases (0.9- and 0.8-fold, respectively).
On the other hand, SRR of YLL indicated a lower burden
in Serbia than in EURO B for both males and females
regarding infectious and parasitic diseases (5.3- and 6.5-
fold, respectively), respiratory infections (5.4- and 6.0-
fold, respectively), perinatal conditions (1.4- and 1.6-
fold, respectively), unintentional injuries (1.6- and 2.0-
fold, respectively), and digestive diseases (1.4- and 1.7-
fold, respectively).
Compared to EURO C, Serbia had a lower burden of YLL
in both males and females for infectious and parasitic dis-
eases (7.1- and 2.9-fold, respectively), unintentional inju-
ries (5.6- and 5.2-fold, respectively), intentional injuries
(4.0- and 2.4-fold, respectively), respiratory infections
(3.7- and 2.3-fold, respectively), digestive diseases (by
1.9-fold in each), neuropsychiatric conditions (by 1.5-
fold in each), and cardiovascular diseases (1.6- and 1.1-
fold, respectively).
Discussion
This research aimed to explore Serbian premature mortal-
ity within the European context as an extension of the
national burden of disease study. Differences between Ser-
bia and European sub-regions were identified in terms of
excess YLL structures and in terms of SRR YLL for selected
diseases, along with age and gender distribution. Accord-
ing to the mortality pattern, Serbia was similar to EURO
B, but with a lower average YLL per death case. The burden
due to cardiovascular diseases and cancers accounted for
approximately two-thirds of the total YLL in Serbia. YLL
patterns indicated similarities between Serbia and EURO
A, while SRR YLL showed similarities between Serbia and
EURO B. Compared to all European sub-regions, Serbia
had a major excess of premature mortality due to neo-
Log-plots of age-specific death rates (per 100,000) by com- municable, maternal, perinatal and nutritional conditions (a);  non-communicable diseases (b); and injuries (c), in Serbia and  Europe in 2000 Figure 1
Log-plots of age-specific death rates (per 100,000) by 
communicable, maternal, perinatal and nutritional 
conditions (a); non-communicable diseases (b); and 
injuries (c), in Serbia and Europe in 2000.
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plasms and diabetes mellitus. Serbia had lost more years
of life than EURO A due to cardiovascular, genitourinary
diseases, and intentional injuries. In addition, in Serbia
the major premature mortality burden shifted towards
middle life years, in particular among males and due to
non-communicable diseases. Yet, Serbia was not as bur-
dened with communicable diseases and injuries as were
EURO B and EURO C.
Some of the identified similarities between Serbia and
Europe with respect to premature mortality were expected
because of the geographical and historical conditions.
Geographically, Serbia borders with countries in EURO A,
the former Yugoslav republic of Croatia [8]. Also, Serbia is
a neighbor of Hungary (EURO C) and the Former Yugo-
slav Republic of Macedonia (EURO B). Some of the dis-
parities could be explained by social and economic
circumstances [6,26,27] and recent developments in Ser-
bia: army conflicts accompanied with waves of internally-
displaced persons and refugees, two huge inflations in
1989 and 1993, several years of economic sanctions, and
NATO bombing in 1999.
The demographic transition, biological, lifestyle, or cul-
tural differences certainly model the mortality pattern [1].
Similar to the results of our study, males had most YLL in
countries with well-established market economies (60%),
and in European countries with former socialist econo-
mies (62%) [28]. The aging of the Serbian population (the
aging index was 1 and the median age around 40 years)
[16] contributed to the compression of morbidity and the
predominance of non-communicable diseases among
adults and the elderly. In addition, the proportion of the
youngest in the Serbian population (about 16% in the age
interval 0 – 14 years) [16] could contribute to the alloca-
tion of burden mainly across the adult population.
Distribution of selected causes of YLL (%) by age intervals and gender in Serbia in 2000 Figure 2
Distribution of selected causes of YLL (%) by age intervals and gender in Serbia in 2000.
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This study had some limitations. Although Serbian regis-
tration of deaths is considered almost complete and with
relatively accurate information on causes of death, 80%
completeness of adult male and female mortality registra-
tion was calculated in two Serbian regions with the Brass
Growth Balance method [12]. Yet, that method is more
suitable for stable populations where partial birth and
death rates from registered deaths have a linear relation-
ship [29]. Nevertheless, the study findings may be biased
due to various sources of mortality data, as well as differ-
ent diagnostics and coding practices across compared
regions. As a precaution, in a following comparative
research, any improvements in the quality of data should
be accounted for. For example, in Serbia data on ill-
defined causes of mortality were almost halved in 2006
(4.8%) compared to 2000 (8.7%) [30]. Advanced work of
the study should consider some issues as in other studies
[31-34], e.g., major conditions within cause categories,
the relationship to ethnicity, residence, employment sta-
tus or level of education, thus providing a more valuable
tool for public health planning.
Notwithstanding the shortcomings, this is the first study
that objectively quantified the premature mortality gap
between Serbia and the European sub-regions. Therefore,
the findings could be used to indicate convergence of cur-
rent national health plans for some diseases with health
plans in Europe. They advocate strategic orientation of
country health planners and decision-makers for public
health activities within Europe and integration of health
protection in other policies at the state level. The results
support country participation in intraregional collabora-
tion that will facilitate initiatives for promotion of healthy
lifestyles and better disease management and that may
improve institutional health care protocols.
Mortality registration needs to be improved at all levels by
modernization of control, knowledge, coding practices,
and death verification procedures. This is of particular rel-
evance regarding adult mortality under-registration, and
for forensic cases, e.g. injuries, since the clinical documen-
tation and death files are among the key elements in jurid-
ical procedures.
YLL (%) by gender, causes, and regions in 2000 Figure 3
YLL (%) by gender, causes, and regions in 2000.
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After several years of slow transition, Serbia should have a
new systematic revision of the national burden of disease
in order to provide a specific aspect on the health sector
reform outcomes and possible improvements within the
European context.
Conclusion
With a premature mortality pattern, Serbia is placed in the
middle of the European triangle. The main excess of YLL
in Serbia was due to cardiovascular, malignant diseases,
and diabetes mellitus. These results may be used for
assessment of unacceptable social risks resulting from
health inequalities. In order to reduce an unfavourable
premature mortality gap, it is necessary to reconsider cer-
tain local polices and practices as well as the financial and
human resources needed for prevention of disease and
injury burden.
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